NCT07012252

Brief Summary

The research aimed to improve surgical techniques and long-term outcomes by utilizing this advanced imaging technology to illuminate the structural abnormalities of the anterior segment in eyes with primary congenital glaucoma.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2018

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2020

Completed
4.6 years until next milestone

First Submitted

Initial submission to the registry

May 31, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 10, 2025

Completed
Last Updated

June 10, 2025

Status Verified

May 1, 2025

Enrollment Period

2.1 years

First QC Date

May 31, 2025

Last Update Submit

May 31, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Central corneal thickness

    Central corneal thickness was measured using handheld anterior segment optical coherence tomography (HH AS-OCT).

    6 months post-procedure

Secondary Outcomes (2)

  • Trabecular-iris angle

    6 months post-procedure

  • Iris thickness

    6 months post-procedure

Study Arms (1)

Primary congenital glaucoma group

EXPERIMENTAL

Infants with primary congenital glaucoma.

Procedure: Optical coherence tomography

Interventions

Infants underwent optical coherence tomography.

Primary congenital glaucoma group

Eligibility Criteria

Age1 Week - 72 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age from 1 to 72 weeks.
  • Both sexes.
  • Infants with primary congenital glaucoma.

You may not qualify if:

  • Eyes in which the angle could not be visualized by the handheld anterior segment optical coherence tomography (HH AS-OCT).
  • Eyes with previous intraocular surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University

Cairo, 12613, Egypt

Location

MeSH Terms

Conditions

Hydrophthalmos

Interventions

Tomography, Optical Coherence

Condition Hierarchy (Ancestors)

Eye AbnormalitiesEye DiseasesGlaucoma, Open-AngleGlaucomaOcular HypertensionCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, Diseases

Intervention Hierarchy (Ancestors)

Tomography, OpticalOptical ImagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisTomographyInvestigative Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Specialist of Ophthalmology at Ministry of Health of Egypt.

Study Record Dates

First Submitted

May 31, 2025

First Posted

June 10, 2025

Study Start

October 1, 2018

Primary Completion

November 1, 2020

Study Completion

November 1, 2020

Last Updated

June 10, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Shared Documents
STUDY PROTOCOL
Time Frame
After the end of study for one year.
Access Criteria
The data will be available upon a reasonable request from the corresponding author.

Locations